FINWIRES · TerminalLIVE
FINWIRES

Wantai Biological Swings to Loss in 2025; Shares Fall 4%

By

-- Beijing Wantai Biological Pharmacy Enterprise (SHA:603392) swung to an attributable loss of 398.3 million yuan in 2025 from an attributable profit of 106.2 million yuan in 2024, according to a Tuesday filing with the Shanghai bourse.

The drug manufacturer logged a loss per share of 0.31 yuan compared with earnings per share of 0.08 yuan in the previous year.

Operating income declined 19% year over year to 1.82 billion yuan from 2.25 billion yuan.

Shares decreased 4% during morning trading on Tuesday.

Related Articles

Asia

Morgan Stanley Upgrades Ganfeng Lithium Group to Overweight from Equalweight; Price Target is 110.40 Yuan

$HKG:1772$SHE:002460
Research

Morgan Stanley Downgrades Tencent Music Entertainment Group to Equalweight from Overweight; Price Target is $12.30

$HKG:1698
Asia

Sangfor Technologies' Attributable Loss Narrows by 74% in Q1

Sangfor Technologies' (SHE:300454) attributable loss narrowed by 74% to 64.5 million yuan in the first quarter from 249.6 million yuan in the year-ago period, according to a Tuesday filing with the Shenzhen bourse.The information technology company's loss per share was 0.15 yuan, narrower by 75% from 0.59 yuan in the prior-year period.Operating revenue grew 29% year over year to 1.63 billion yuan from 1.26 billion yuan.

$SHE:300454